Effect of pravastatin in the treatment of hypercholesterolemia after renal transplantation under cyclosporine and prednisone

Transplant Proc. 1995 Aug;27(4):2217-20.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apolipoprotein A-I / blood
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Cyclosporine / therapeutic use*
  • Drug Administration Schedule
  • Female
  • Humans
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / drug therapy*
  • Hypercholesterolemia / etiology
  • Immunosuppression Therapy / methods
  • Kidney Transplantation / adverse effects
  • Kidney Transplantation / immunology
  • Kidney Transplantation / physiology*
  • Male
  • Middle Aged
  • Muromonab-CD3 / therapeutic use*
  • Pravastatin / therapeutic use*
  • Prednisone / therapeutic use*

Substances

  • Apolipoprotein A-I
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Muromonab-CD3
  • Cyclosporine
  • Cholesterol
  • Pravastatin
  • Prednisone